Intended for healthcare professionals

Analysis

Raising the bar for using surrogate endpoints in drug regulation and health technology assessment

BMJ 2021; 374 doi: https://doi.org/10.1136/bmj.n2191 (Published 16 September 2021) Cite this as: BMJ 2021;374:n2191

Linked Feature

Should regulatory authorities approve drugs based on surrogate endpoints?

Article usage

Article metrics provide readers and authors with an indication of how often a specific article has been accessed month by month. It counts three formats - abstract/extract, full text and pdf. The page is updated each day.

Usage statistics: September 2021 to June 2024

Rendering graph...
AbstractFullPdf
Sep 202112734720686
Oct 20211138133119
Nov 202178892123
Dec 20216217092
Jan 20225377993
Feb 20226134286
Mar 20226586545
Apr 20224044721
May 20223994312
Jun 20224158946
Jul 20222685713
Aug 20223445329
Sep 20223255717
Oct 20224386313
Nov 20222554526
Dec 20223052212
Jan 20232572214
Feb 20231661911
Mar 20232933629
Apr 20231941912
May 20232134214
Jun 20231983921
Jul 2023201203
Aug 20233253814
Sep 20231792410
Oct 20232803512
Nov 2023176228
Dec 2023192137
Jan 20242522010
Feb 20242043420
Mar 2024121179
Apr 202439613510
May 20241951612
Jun 20246184
Total1268462361653